Dreams do come true. Universities are continually looking for corporate sponsors to fund any research project irrespective of what outcome may be achieved. In this case they can thank MXC shareholders for their contribution. This arrangement however is slightly better than signing just another distribution deal where you actually need product to send through those channels. Insofar as research is concerned, you never know what could come out of it in a commercial sense. Anything around cancer cure is likely to cause interest but its unlikely to be anywhere near a "cure all". Proven product distributed through distribution channels is what we are all waiting for.
MXC Price at posting:
4.3¢ Sentiment: None Disclosure: Held
